Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,otherLiab,goodWill,treasuryStock,otherAssets,cash,totalCurrentLiabilities,deferredLongTermAssetCharges,shortLongTermDebt,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,longTermInvestments,netReceivables,longTermDebt,inventory,accountsPayable,shortTermInvestments,investments,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,changeToInventory,changeToAccountReceivables,otherCashflowsFromFinancingActivities,changeToNetincome,capitalExpenditures,dividendsPaid,repurchaseOfStock,WC,language,region,quoteType,triggerable,quoteSourceName,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,trailingAnnualDividendRate,trailingPE,trailingAnnualDividendYield,epsTrailingTwelveMonths,epsForward,currency,priceHint,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,forwardPE,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,exchange,exchangeDataDelayedBy,esgPopulated,tradeable,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,shortName,market,marketState,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,compensationRisk,auditRisk,longBusinessSummary,city,phone,shareHolderRightsRisk,compensationAsOfEpochDate,governanceEpochDate,boardRisk,country,website,maxAge,overallRisk,address1,industry
t0,FME.DE,-3042334000.0,292888000,48645000,,398181000,1201581000,248946000,711515000,1206657000,446497000,446497000,,-91328000,,,,93847000,4210125000,3763628000,3003468000,-48316000,,304334000,248946000,1401497000.0,2887037000.0,19958883000.0,11998075000.0,3937841000.0,33158539000.0,292888000.0,832376000.0,10500006000.0,2379690000.0,13638912000.0,-1681856000.0,1186483000.0,1073478000.0,7242973000.0,333286000.0,785475000.0,-1681856000.0,8415643000.0,7789409000.0,726595000.0,3894150000.0,6315270000.0,1989405000.0,711173000.0,,59520000.0,-105292000.0,-224053000.0,23867000.0,-35915000.0,170572000.0,575000.0,-8061000.0,44259000.0,207648000.0,386900000.0,-41423000.0,-480524000.0,-60357000.0,-40443000.0,-184301000.0,,,546436000.0,en-US,US,EQUITY,False,Delayed Quote,0.4305024,65.3 - 66.7,65.04,65.34,65.36,387,1053,finmb_384522,XETRA,Fresenius Medical Care AG & Co. KGaA,EUR,466140,344397,10.139999,0.18376222,55.18 - 75.08,-9.760002,-0.12999469,55.18,75.08,1635822000,1635822000,1635822000,1.34,16.917896,0.020602707,3.861,4.42,EUR,2,40.965,68.34167,-3.0216675,-0.044214133,65.51169,-0.19168854,-0.0029260204,19131443200,14.77828,1.5945319,15,Europe/Berlin,CEST,7200000,GER,0,False,False,65.32,1630510511,0.27999878,65.92,66.7,65.3,441973,FRESENIUS MEDICAL CARE AG & CO ,de_market,POSTPOST,1.01,,,75.08,55.18,68.34,65.51,466.14k,344.4k,292.89M,,198.58M,32.23%,33.25%,,,,,,1.34,1.91%,1.34,2.06%,,31.09%,,"May 21, 2021",3:1,"Jun 18, 2007","Dec 31, 2020","Mar 31, 2021",6.43%,12.85%,4.20%,10.50%,17.58B,60.04,-6.20%,5.54B,3.09B,1.13B,3.86,-11.90%,1.07B,3.66,12.9B,97.74,1.08,40.97,3.86B,2.25B,Value,61352,Healthcare,124995,3,10,"Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2020, it operated 4,092 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.",Bad Homburg,49 6172 609 0,1,1609372800,1625011200,5,Germany,http://www.freseniusmedicalcare.com,86400,6,Else-KrOener Strasse 1,Medical Care Facilities
t-1,FME.DE,-3124657000.0,292888000,52428000,,377407000,1116230000,177184000,711247000,1348720000,585045000,585045000,,-98658000,,,,138606000,4400154000,3815109000,3051434000,-207638000,,238801000,177184000,1381009000.0,2872630000.0,19357726000.0,11215080000.0,2421294000.0,31689036000.0,292877000.0,462186000.0,10254913000.0,2514850000.0,12958728000.0,-2205340000.0,1126124000.0,1081539000.0,6159644000.0,351152000.0,1008359000.0,-2205340000.0,8186752000.0,7275310000.0,761113000.0,3619040000.0,6800101000.0,1895310000.0,794932000.0,179265000.0,-62395000.0,-113267000.0,-454348000.0,-518349000.0,-568588000.0,152567000.0,2187000.0,-517120000.0,-78369000.0,584185000.0,346599000.0,-42314000.0,53122000.0,-52426000.0,-260104000.0,-306374000.0,,,1115666000.0,en-US,US,EQUITY,False,Delayed Quote,0.4305024,65.3 - 66.7,65.04,65.34,65.36,387,1053,finmb_384522,XETRA,Fresenius Medical Care AG & Co. KGaA,EUR,466140,344397,10.139999,0.18376222,55.18 - 75.08,-9.760002,-0.12999469,55.18,75.08,1635822000,1635822000,1635822000,1.34,16.917896,0.020602707,3.861,4.42,EUR,2,40.965,68.34167,-3.0216675,-0.044214133,65.51169,-0.19168854,-0.0029260204,19131443200,14.77828,1.5945319,15,Europe/Berlin,CEST,7200000,GER,0,False,False,65.32,1630510511,0.27999878,65.92,66.7,65.3,441973,FRESENIUS MEDICAL CARE AG & CO ,de_market,POSTPOST,1.01,,,75.08,55.18,68.34,65.51,466.14k,344.4k,292.89M,,198.58M,32.23%,33.25%,,,,,,1.34,1.91%,1.34,2.06%,,31.09%,,"May 21, 2021",3:1,"Jun 18, 2007","Dec 31, 2020","Mar 31, 2021",6.43%,12.85%,4.20%,10.50%,17.58B,60.04,-6.20%,5.54B,3.09B,1.13B,3.86,-11.90%,1.07B,3.66,12.9B,97.74,1.08,40.97,3.86B,2.25B,Value,61352,Healthcare,124995,3,10,"Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2020, it operated 4,092 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.",Bad Homburg,49 6172 609 0,1,1609372800,1625011200,5,Germany,http://www.freseniusmedicalcare.com,86400,6,Else-KrOener Strasse 1,Medical Care Facilities
t-2,FME.DE,-3515567000.0,292888000,44923000,,544088000,1162651000,353502000,717750000,1367044000,604371000,604371000,,-95223000,,,,124342000,4413768000,3809397000,3046724000,-60283000,,419746000,353502000,1419384000.0,3593311000.0,20393373000.0,11493111000.0,4117292000.0,33049135000.0,304629000.0,938304000.0,10054892000.0,2362472000.0,13589294000.0,-2459721000.0,1165637000.0,1598659000.0,7043154000.0,429150000.0,1046030000.0,-1723231000.0,8343758000.0,7824068000.0,706994000.0,3390088000.0,6979668000.0,1897017000.0,798296000.0,,-2664000.0,77272000.0,-287670000.0,-284300000.0,-693139000.0,-194041000.0,1087000.0,-290774000.0,-55618000.0,745653000.0,394934000.0,-111621000.0,74062000.0,-58756000.0,87783000.0,-245441000.0,-351170000.0,,780914000.0,en-US,US,EQUITY,False,Delayed Quote,0.4305024,65.3 - 66.7,65.04,65.34,65.36,387,1053,finmb_384522,XETRA,Fresenius Medical Care AG & Co. KGaA,EUR,466140,344397,10.139999,0.18376222,55.18 - 75.08,-9.760002,-0.12999469,55.18,75.08,1635822000,1635822000,1635822000,1.34,16.917896,0.020602707,3.861,4.42,EUR,2,40.965,68.34167,-3.0216675,-0.044214133,65.51169,-0.19168854,-0.0029260204,19131443200,14.77828,1.5945319,15,Europe/Berlin,CEST,7200000,GER,0,False,False,65.32,1630510511,0.27999878,65.92,66.7,65.3,441973,FRESENIUS MEDICAL CARE AG & CO ,de_market,POSTPOST,1.01,,,75.08,55.18,68.34,65.51,466.14k,344.4k,292.89M,,198.58M,32.23%,33.25%,,,,,,1.34,1.91%,1.34,2.06%,,31.09%,,"May 21, 2021",3:1,"Jun 18, 2007","Dec 31, 2020","Mar 31, 2021",6.43%,12.85%,4.20%,10.50%,17.58B,60.04,-6.20%,5.54B,3.09B,1.13B,3.86,-11.90%,1.07B,3.66,12.9B,97.74,1.08,40.97,3.86B,2.25B,Value,61352,Healthcare,124995,3,10,"Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2020, it operated 4,092 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.",Bad Homburg,49 6172 609 0,1,1609372800,1625011200,5,Germany,http://www.freseniusmedicalcare.com,86400,6,Else-KrOener Strasse 1,Medical Care Facilities
t-3,FME.DE,-3381916000.0,292888000,50506000,,563984000,1197025000,350972000,738077000,1436010000,647427000,647427000,,-103127000,,,,137068000,4557345000,3909918000,3121335000,-83443000,,426916000,350972000,1447308000.0,3590176000.0,20867231000.0,12125597000.0,4216381000.0,34189853000.0,304608000.0,869848000.0,10077917000.0,2359903000.0,14060205000.0,-1847104000.0,1192516000.0,1889433000.0,8064013000.0,391344000.0,1512658000.0,-1110614000.0,8622278000.0,8181521000.0,686025000.0,3581385000.0,6273995000.0,1840855000.0,755531000.0,,-2664000.0,1311586000.0,-280591000.0,-1231969000.0,-1523614000.0,-118085000.0,8964000.0,484381000.0,-30665000.0,2319251000.0,402591000.0,-119666000.0,199159000.0,-150744000.0,277727000.0,-218191000.0,-351170000.0,-149865000.0,117508000.0,en-US,US,EQUITY,False,Delayed Quote,0.4305024,65.3 - 66.7,65.04,65.34,65.36,387,1053,finmb_384522,XETRA,Fresenius Medical Care AG & Co. KGaA,EUR,466140,344397,10.139999,0.18376222,55.18 - 75.08,-9.760002,-0.12999469,55.18,75.08,1635822000,1635822000,1635822000,1.34,16.917896,0.020602707,3.861,4.42,EUR,2,40.965,68.34167,-3.0216675,-0.044214133,65.51169,-0.19168854,-0.0029260204,19131443200,14.77828,1.5945319,15,Europe/Berlin,CEST,7200000,GER,0,False,False,65.32,1630510511,0.27999878,65.92,66.7,65.3,441973,FRESENIUS MEDICAL CARE AG & CO ,de_market,POSTPOST,1.01,,,75.08,55.18,68.34,65.51,466.14k,344.4k,292.89M,,198.58M,32.23%,33.25%,,,,,,1.34,1.91%,1.34,2.06%,,31.09%,,"May 21, 2021",3:1,"Jun 18, 2007","Dec 31, 2020","Mar 31, 2021",6.43%,12.85%,4.20%,10.50%,17.58B,60.04,-6.20%,5.54B,3.09B,1.13B,3.86,-11.90%,1.07B,3.66,12.9B,97.74,1.08,40.97,3.86B,2.25B,Value,61352,Healthcare,124995,3,10,"Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2020, it operated 4,092 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.",Bad Homburg,49 6172 609 0,1,1609372800,1625011200,5,Germany,http://www.freseniusmedicalcare.com,86400,6,Else-KrOener Strasse 1,Medical Care Facilities
